Sterile Processing

Following a two-day summit convened by the FDA and AAMI in October 2011, AAMI released a post-event publication in December 2011 that captured the essence of the summit, outlined the priorities, and established a path forward.

I have been around long enough to see many changes in the way items are processed for reuse in healthcare. Years ago, cleaning, packaging and sterilization took place in many different locations throughout a healthcare facility. Most of the time, these functions took place in the user departments, and the thought of centralizing these functions was not always met with enthusiasm. It was difficult for the end-user to envision someone else processing items that were essential to their delivery of quality patient care.

It is illegal in some parts of the country to dump used OPA or glutaraldehyde down the drain without neutralizing it first. It is a popular misconception that used OPA or glutaraldehyde is no longer dangerous (biocidal) after it has passed its reuse date or it has failed a MRC test. Not only can used disinfectants adversely affect the sewer system, but they can be dangerous to the healthcare worker as well.

There is nothing more challenging to effective cleaning than receiving instruments in the decontamination area that have dried blood on them. Reducing this concern has always been an issue.

In the May 2012 print issue of ICT, we explore the dialogue in the sterile processing community that was sparked by a report in the mainstream media on dirty surgical instruments. In actuality, the genesis of the TODAY Show segment and a report from the Center for Public Integrity is rooted in a study in the December 2011 issue of the journal Infection Control and Hospital Epidemiology by Pritish Tosh, MD, of the Mayo Clinic Division of Infectious Diseases, and colleagues, who reported on organ/space surgical site infections (SSIs) that occurred after arthroscopic procedures and were due to Pseudomonas aeruginosa of indistinguishable pulsed-field gel electrophoresis (PFGE) patterns occurring at a Texas hospital from April through May 2009.

Chris Lavanchy, engineering director of the Health Devices Group at ECRI Institute, has extensive experience working with sterile processing departments and provides his insights regarding the imperatives of proper medical device reprocessing.